Singapore sovereign wealth fund GIC to invest US$75 million in Chinese drug maker Ascletis’ Hong Kong IPO

Ascletis Pharma, the first biotechnology firm to file for an IPO in Hong Kong following recent listing reforms, has secured commitment from Singapore sovereign wealth manager GIC to become a cornersto…
( read original story …)


Related Post